Related references
Note: Only part of the references are listed.Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Robert A. Adler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Failure modelling of trabecular bone using a non-linear combined damage and fracture voxel finite element approach
Noel M. Harrison et al.
BIOMECHANICS AND MODELING IN MECHANOBIOLOGY (2013)
Finite element modeling mesh quality, energy balance and validation methods: A review with recommendations associated with the modeling of bone tissue
Timothy A. Burkhart et al.
JOURNAL OF BIOMECHANICS (2013)
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Raphael P. H. Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Intrinsic Material Properties of Trabecular Bone by Nanoindentation Testing of Biopsies Taken from Healthy Women Before and After Menopause
Benjamin J. Polly et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Bone Micromechanical Properties Are Compromised During Long-Term Alendronate Therapy Independently of Mineralization
Yohann Bala et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Incidence of Atypical Nontraumatic Diaphyseal Fractures of the Femur
Richard M. Dell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Differences in Bone Quality in Low- and High-Turnover Renal Osteodystrophy
Hartmut H. Malluche et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Bisphosphonates for Osteoporosis - Where Do We Go from Here?
Marcea Whitaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Role of Trabecular Microarchitecture in the Formation, Accumulation, and Morphology of Microdamage in Human Cancellous Bone
Lamya Karim et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Risks and benefits of long-term bisphosphonate therapy
Ginelle A. Schmidt et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
A Longitudinal HR-pQCT Study of Alendronate Treatment in Postmenopausal Women With Low Bone Density: Relations Among Density, Cortical and Trabecular Microarchitecture, Biomechanics, and Bone Turnover
Andrew J. Burghardt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Safety of Bisphosphonates in the Treatment of Osteoporosis
Robert R. Recker et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
John P. Bilezikian
AMERICAN JOURNAL OF MEDICINE (2009)
Trabecular bone strength predictions using finite element analysis of micro-scale images at limited spatial resolution
Grant Bevill et al.
BONE (2009)
Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method
K. Imai et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method
Joshua A. MacNeil et al.
BONE (2008)
Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans
Tony M. Keaveny et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Validation of a voxel-based FE method for prediction of the uniaxial apparent modulus of human trabecular bone using macroscopic mechanical tests and nanoindentation
Yan Chevalier et al.
JOURNAL OF BIOMECHANICS (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The interaction of microstructure and volume fraction in predicting failure in cancellous bone
Ara Nazarian et al.
BONE (2006)
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
B Borah et al.
BONE (2006)
The effects of side-artifacts on the elastic modulus of trabecular bone
Kerern Un et al.
JOURNAL OF BIOMECHANICS (2006)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties
JS Day et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2004)
Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography
B Borah et al.
BONE (2004)
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study
SCE Schuit et al.
BONE (2004)
An improved segmentation method for in vivo μCT Imaging
JH Waarsing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography
B Borah et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images
W Pistoia et al.
BONE (2002)
Biomechanics of bone: Determinants of skeletal fragility and bone quality
CH Turner
OSTEOPOROSIS INTERNATIONAL (2002)
Share Paper
